A team of researchers has discovered a previously unknown population of neurons in the hypothalamus that regulate food intake and could be a promising new target for obesity drugs, according to a ...
Researchers have uncovered a serious side effect of using the CRISPR-Cas gene scissors. A molecule designed to make the process more efficient destroys parts of the genome.
CMS has negotiated outcomes-based agreements for sickle cell gene therapies with the two companies on behalf of participating state Medicaid programs.
Antimicrobial resistance (AMR) is a critical global health crisis that undermines the effectiveness of antibiotics, leading ...
The Centers for Medicare & Medicaid Services said on Wednesday it had entered into agreements with Vertex Pharmaceuticals and ...
Vertex Pharmaceuticals Inc. and bluebird bio Inc. — are the first to take part in a new Medicaid model intended to expand ...
But truly deleting your personal genetic information from the DNA testing company is easier said than done. The award ...
Monte Rosa Therapeutics stock surged after a recent partnership with Novartis, despite limited clinical results. Can the ...
Thanks to CRISPR, our medical specialists will soon have unprecedented control over how they treat and prevent some of our ...
US scientists have developed a new CRISPR toolkit to boost the treatment of genetic disorders SCIENCE & TECHNOLOGY ...
Genome editing with various CRISPR-Cas molecule complexes has progressed rapidly in recent years. Hundreds of labs around the ...
The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders.